Privia Health Group, Inc. (PRVA) Stock Overview
Explore Privia Health Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Privia Health Group, Inc. (PRVA)
Key Financials
Key Financials
Market Cap
2.7B
P/E Ratio
96.61
EPS (TTM)
$0.21
ROE
0.00%
PRVA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Privia Health Group, Inc. (NASDAQ: PRVA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Privia Health Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PRVA on the NASDAQ shows an RSI of 30.13, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $24.07 for the NASDAQ listing.
Key metrics behind Privia Health Group, Inc.'s NASDAQ-traded stock include a P/E ratio of 96.61 and a market capitalization of 2.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRVA on the NASDAQ.